Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lauren Barron

Psychiatry Columbia, SC Medical Doctor

NPI 1508151358 CMS profile 295405

1415 Blanding St, Ste 4, Columbia, SC 29201

Open in the dashboard

General payments

$5,725

319 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lauren Barron of Columbia, SC is reported in the CMS Open Payments database as having received $5,725 across 319 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $993 51
2024 General $763 52
2023 General $1,489 70
2022 General $944 58
2021 General $581 36
2020 General $112 7
2019 General $843 45

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lauren Barron
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Lauren Barron were reported at $993. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Lauren Barron Psychiatry median Middle half National median
2019 $843 $184 $59–$605 $163
2020 $112 $119 $36–$372 $114
2021 $581 $143 $43–$576 $132
2022 $944 $153 $50–$590 $149
2023 $1,489 $170 $56–$651 $160
2024 $763 $179 $57–$673 $164
2025 $993 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $655 63 payments
  2. Janssen Pharmaceuticals, Inc $547 25 payments
  3. Otsuka America Pharmaceutical, Inc. $546 30 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $537 31 payments
  5. Abiomed $524 6 payments
  6. Supernus Pharmaceuticals, Inc. $348 20 payments
  7. Ironshore Pharmaceuticals Inc. $342 19 payments
  8. Tris Pharma Inc $323 19 payments
  9. Lundbeck LLC $301 18 payments
  10. Corium, Inc. $294 17 payments
  11. Other $1,308 71 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,725 319 payments
Products named General payments · program years 2019–2025
  1. VRAYLAR $608 60 payments
  2. Impella $524 6 payments
  3. REXULTI Psychiatry $511 28 payments
  4. TRINTELLIX $488 28 payments
  5. SPRAVATO $430 19 payments
  6. Azstarys $294 17 payments
  7. Dyanavel XR $270 15 payments
  8. Adzenys XR-ODT $232 13 payments
  9. Qelbree $231 13 payments
  10. REXULTI Psychiatry $217 13 payments
  11. Other $2,479 141 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

319 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record